I am a neurosurgery resident at the University of Toronto. In 2012 I left residency to pursue a PhD in developmental neurobiology at Stanford University. While at Stanford I entered a highly interdisciplinary project aimed at identifying novel drug targets for pediatric brain cancer. Ultimately, this led to a clinical trial for a promising new drug for the treatment of medulloblastoma, the most common pediatric brain cancer, which is planned to begin winter 2018.

Experience

  • –present
    MD/PhD, Stanford University

Education

  • 2018 
    Stanford University, MD (2009), PhD (2018)